480. In Vivo Gene Targeting for HIV Immunoprophylaxis Using Promoterless AAV Without Nucleases

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34089-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Efficient Gene Targeting by TAL Effector Nucleases Coinjected With Exonucleases in Zygotes

Scientific Reports
Multidisciplinary
2013English

Precise Genome Modification via Sequence-Specific Nucleases-Mediated Gene Targeting for Crop Improvement

Frontiers in Plant Science
Plant Science
2016English

Gene Targeting Technologies in Rats: Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases, and Clustered Regularly Interspaced Short Palindromic Repeats

Development Growth and Differentiation
MedicineDevelopmental BiologyCell Biology
2013English

Naturally Enveloped AAV Vectors for Shielding Neutralizing Antibodies and Robust Gene Delivery in Vivo

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2014English

Gene Targeting With Zinc Finger Nucleases to Produce Cloned eGFP Knockout Pigs

Molecular Reproduction and Development
GeneticsDevelopmental BiologyCell Biology
2011English

AAV-mediated Gene Therapy Targeting TRPV4 Mechanotransduction for Inhibition of Pulmonary Vascular Leakage

APL Bioengineering
2019English

330. Comparing Dual AAV Vector Strategy Efficiencies for Gene Therapy in Vitro and in Vivo

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Targeting Gene Expression to Cones With Human Cone Opsin Promoters in Recombinant AAV

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy